Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1584-1588

  Wenisch, Christoph ^a   Bartunek, Anna ^a   Zedtwitz Liebenstein, Konstantin ^a   Hiesmayr, Michael ^a   Parschalk, Bernhard ^a   Pernerstorfer, Thomas ^a   Graninger, Wolfgang ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CEFODIZIME; CEFUROXIME;

ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PHAGOCYTOSIS; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS;

EID: 0030757231     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1584     Document Type: Article

References (41)

1. Auteri, A., A. L. Pasqui, F. Bruni, M. Saletti, S. Mazza, M. Di Renzo, D. Maggiore, and T. Di Perri. 1991. Effect of cefodizime (HR 221) on immunological defects induced by surgical stress. Drugs 12:555-561.
2. Bardosi, L., and M. Tekeres. 1985. Impaired metabolic activity of phagocytic cells after anaesthesia and surgery. Br. J. Anaesth. 57:520-523.
3. Bass, D. A., J. W. Pearce, L. R. Dechobelet, P. Szejda, M. Seeds, and M. Thomas. 1983. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130: 1910-1917.
4. Bassoe, C. F., and C. O. Solberg. 1984. Phagocytosis of Staphylococcus aureus by human leukocytes: quantification by a flow cytometric and a microbiological method. Acta Pathol. Microbiol. Scand. Sect. C 92:43-50.
5. Bassoe, C. F., O. D. Coevum, C. O. Solberg, and B. Honeberg. 1983. Phagocytosis of bacteria by human leukocytes measured by flow cytometry (41722). Proc. Soc. Exp. Biol. Med. 174:182-186.
6. Bjerknes, R., and C. F. Bossoe. 1983. Human leukocyte phagocytosis of zymosan particles measured by flow cytometry. Acta Pathol. Microbiol. Scand. Sect. C 91:341.
7. Böhmer, R. H., L. S. Trinkle, and J. L. Staneck. 1992. Dose effects of LPS on neutrophils in a whole blood flow cytometric assay of phagocytosis and oxidative burst. Cytometry 13:525-531.
8. Brody, J. I., N. J. Pickering, G. B. Fink, and E. D. Behr. 1987. Altered lymphocyte subsets during cardiopulmonary bypass. Am. J. Clin. Pathol. 87:626-628.
9. Broek, P. J. 1989. Antimicrobial drugs, microorganisms, and phagocytes. Rev. Infect. Dis. 11:213-245.
10. Bruce, D. L., and D. W. Wingard. 1971. Anesthesia and the immune response. Anesthesiology 34:271-276.
11. Chenowerth, D. E., S. W. Cooper, I. E. Hugli, R. W. Stewart, E. H. Blackstone, and J. W. Kirklin. 1981. Complement activation during cardiopulmonary bypass. N. Engl. J. Med. 304:497-503.
12. Donovan, A. J. 1967. The effect of surgery on reticuloendothelial function. Arch. Surg. 94:247-253.
13. Dunn, P. A., and H. W. Tyver. 1981. Quantitation of neutrophil phagocytosis using fluorescent latex beads. J. Lab. Clin. Med. 98:374.
14. Hairston, P., J. P. Manos, C. D. Graber, and W. H. Lee. 1969. Depression of immunologic surveillance by pump-oxygenation perfusion. J. Surg. Res. 9:587-593.
15. Hammerschmidt, D. E., D. F. Stroncek, T. K. Bowers, C. J. Lammi-Keefe, D. M. Kurth, A. Ozalins, D. M. Nicoloff, R. C. Lillehei, P. R. Craddock, and H. S. Jakob. 1981. Complement activation and neutropcnia occurring during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 81:370-377.
16. Hansen, B. G. 1982. The occurrence of Staphylococcus epidermidis in a department of thoracic and cardiovascular surgery. Scand. J. Thorac. Cardiovasc. Surg. 16:269-274.
17. Hisatomi, K., T. Isomura, T. Kawara, M. Yamashita, A. Hirano, H. Yoshida, N. Eriguchi, K. Kosuga, and K. Ohishi. 1989. Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations. J. Thorac. Cardiovasc. Surg. 98:580-591.
18. Jay, S. J. 1983. Nosocomial infections. Med. Clin. North Am. 67:1251-1277.
19. Kääb, S., G. Pilz, E. Kreuzer, and K. Werdan. 1991. Apache II score in the early diagnosis of septic complications after cardiac surgery. Circ. Shock 34:44.
20. Kirklin, J. K., S. Westaby, E. H. Blackstone, J. W. Kirklin, D. E. Chenoweth, and A. P. Pacifico. 1983. Complement and damaging effects of cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 86:845-857.
21. Labro, M. T. 1990. Cefodizime as a biological response modifier: a review of its in vivo, ex vivo and in vitro immunomodulatory properties. J. Antimicrob. Chemother. 28(Suppl. C):37-47.
22. Labro, M. T. 1993. Immunomodulation by antibacterial agents: is it clinically relevant? Drugs 45:319-328.
23. Labro, M. T., N. Amit, C. Babin-Chevaye, and J. Hakin. 1987. Cefodizime (HR-221) potentiation of human neutrophil oxygen-independent bactericidal activity. J. Antimicrob. Chemother. 19:331-341.
24. Maderato, E. G., P. A. Ward, and R. W. Yurt. 1983. PMN dysfunction in the surgical patient. Infect. Surg. 2:54-61.
25. Markewitz, A., E. Faist, T. Niesel, S. Lang, C. Weinhold, and B. Reichart. 1992. Changes in lymphocyte subsets and mitogen responsiveness following open-heart surgery and possible therapeutic approaches. Thorac. Cardiovasc. Surg. 40:14-18.
26. Markewitz, A., E. Faist, C. Weinhold, S. Lang, S. Endres, L. Hültner, and B. Reichart. 1993. Alterations of cell-mediated immune response following cardiac surgery. Cardiothorac. Surg. 7:193-199.
27. Miholic, J., M. Hudec, E. Domanig, H. Hiertz, W. Klepetko, F. Lackner, and E. Wolner. 1985. Risk factors for severe bacterial infections after valve replacement and aortocoronary bypass operations: analysis of 246 cases by logistic regression. Ann. Thorac. Surg. 40:224-228.
28. Nguyen, D. M., D. S. Mulder, and H. Shennib. 1992. Effect of cardiopulmonary bypass on circulating lymphocyte function. Ann. Thorac. Surg. 53:611-616.
29. Norenberg, R. G., G. K. Sethi, S. M. Scott, and T. Takaro. 1975. Opportunistic endocarditis following open heart surgery. Ann. Thorac. Surg. 10:592-596.
30. Pacheco, Y., R. Hosni, E. E. Dagrosa, F. Gormand, B. Guibert, B. Chabannes, M. Lagarde, and M. Perrin-Fayolle. 1994. Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. Arzneim.-Forsch. 44:559-563.
31. Peritcaravi, S., G. Presani, M. A. Mangiarobbi, and E. Bonfi. 1991. Simultaneous flow cytometric method to measure phagocytosis and oxidative products by neutrophils. Cytometry 12:687-693.
32. Riddle, P. R., M. C. Berembaum, and M. C. Path. 1967. Postoperative depression of the lymphocyte response to phytohemagglutine. Lancet i:746-751.
33. Roilides, E., T. J. Walsh, P. A. Pizzo, and M. Rubin. 1991. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J. Infect. Dis. 163:579-583.
34. Roth, J. A., S. H. Golub, R. A. Cukignan, J. Brazier, and D. L. Morton. 1980. Cell-mediated immunity is depressed following cardiopulmonary bypass. Ann. Thorac. Surg. 31:350-356.
35. Slade, M. S., R. L. Simmons, E. Yunis, and L. J. Greenberg. 1975. Immunodepression after major surgery in normal patients. Surgery 78:363-368.
36. Szejda, P., J. W. Paree, M. S. Seeds, and D. A. Boss. 1984. Flow cytometric quantification of oxidative product formation by polymorphonuclear leukocytes during phagocytosis. J. Immunol. 130:3303-3307.
37. Vanholder, R., E. E. Dagrosa, N. Landschoot, M. A. Watenloss, and S. M. G. Ringoir. 1993. Antibiotics and energy delivery to the phagocytosis associated respiratory burst on chronic hemodialysis patients: a comparison between cefodizime and cotrimoxazole. Nephron 63:65-72.
38. von Velzen-Blad, H., Y. J. Dijkstra, G. A. Schurink, H. A. Verbrugh, J. Verhoef, B. J. M. Zegers, and R. E. Ballieux. 1985. Cardiopulmonary bypass host defense functions in human beings. I. Serum levels and role of immunoglobulins and complement in phagocytosis. Ann. Thorac. Surg. 39:207-211.
39. Wenisch, C., B. Parschalk, M. Hasenhündl, E. Wiesinger, and W. Graninger. 1995. Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections. Antimicrob. Agents Chemother. 39:672-676.
40. Young, L. S. 1981. Nosocomial infections in the immunocompromised adult. Am. J. Med. 70:398-404.
41. Zimmermann, J. J., J. R. Millard, and C. Farrin-Rusk. 1989. Septic plasma suppresses superoxide anion synthesis by normal homologous polymorphonuclear leukocytes. Crit. Care Med. 12:1241-1246.